Pralsetinib News

Latest Articles

• Long-Term Clinical Data Reveals Pralsetinib Dramatically Extends Survival for Patients With Advanced RET Fusion Lung Cancer

  Published: Apr 2, 2026

  Section: Medical News

  A 42-month follow-up study of the ARROW clinical trial demonstrates that the targeted therapy pralsetinib increases median survival to 44 months for patients with specific genetic...